NT5E and colorectal carcinoma: While CD73 is widely acknowledged as a tumor promoting protein and its inhibition of this effect would be beneficial for CRC treatment (Yang et al. 2021), there are challenges and limitations in the application of immunotherapies to CRC patients (32).